secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2023-08-08T23:59:59+00:00
Accession:  0001493152-23-027101
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD reports Q2 revenue up 9.6% to $1.65M; secures up to $113.6M private placement
--------------------------------------------------------------------------------

- Closed transformational private placement: $42.2M upfront, up to $71.4M additional on milestone warrants.
- Completed enrollment in C-Guardians IDE trial; anticipates PMA submission in H2 2024.
- Q2 CGuard EPS revenue $1.65M (+9.6% YoY); units sold 2,804 (+7.8% YoY).
- Net loss $5.08M ($0.24 per share) vs $4.64M ($0.59) in Q2 2022.
- Cash $47M as of June 30, up from $17.8M at Dec 31, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315223027101/0001493152-23-027101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315223027101/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-027101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer